Company: REVB
Filing Date: 2025-05-20
Form Type: S-1
Source: 0001213900-25-045828
Chunk: 177

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-05-20
Form: S-1
Chunk 177
---
 2025 Restricted Stock Award (“RSA”)               
 grant to Mr. Rolke, (iii) 2 shares of common stock from Rollover RSU’s vesting and issuable within 60 days to Mr. Rolke, 
 and (iv) 3 shares of common stock underlying Stock Options exercisable within 60 days by Mr. Rolke.                      |

| (3) | Consists of (i) 87 shares of common stock held by George                                                                     
 Tidmarsh, Trustee George Francis Tidmarsh 2021 Irrevocable Trust, (ii) 181 shares of common stock from the February 11, 2025 
 RSA grant to Dr. Tidmarsh, and (iii) 13 shares of common stock underlying Stock Options exercisable within 60 days by        
 Dr. Tidmarsh.                                                                                                                |

| (4) | Consists of (i) 6 shares of common stock held directly                                                                
 by Ms. Carver (ii) 181 shares of common stock from the February 11, 2025 RSA grant to Ms. Carver, and (iii) 13 shares 
 of common stock underlying Stock Options exercisable within 60 days by Ms. Carver.                                    |

| (5) | Consists of (i) 2 shares of common stock held directly                                                       
 by Mr. Roper (ii) 181 shares of common stock from the February 11, 2025 RSA grant to Mr. Roper, and (iii) 13 
 shares of common stock underlying Stock Options exercisable within 60 days by Mr. Roper.                     |

| (6) | Consists of 181 shares of common stock from the February 11, 
 2025 RSA grant to Dr. Chawla.                                |

| (7) | Consists of (i) 28 shares of common stock held by The                                                                       
 Zygmont Family Trust Dated October 25, 2016, (ii) 13 shares of common stock held by Czeslaw Capital Fund, LLC, (iii) 15,048 
 shares of common stock from the February 11, 2025 RSA grant to Mr. Zygmont, and (iv) 1 shares of common stock underlying    
 Stock Options exercisable within 60 days by Mr. Zygmont.                                                                    |

110 PLAN OF DISTRIBUTION Pursuant to a placement agency agreement, dated as of , 2025, we have engaged Roth Capital